Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 650

1.

Prognostic significance of STAT3 expression and its correlation with chemoresistance of non-small cell lung cancer cells.

Yin Z, Zhang Y, Li Y, Lv T, Liu J, Wang X.

Acta Histochem. 2012 Feb;114(2):151-8. doi: 10.1016/j.acthis.2011.04.002. Epub 2011 May 6.

PMID:
21549414
[PubMed - indexed for MEDLINE]
2.

Overexpression of STAT3 potentiates growth, survival, and radioresistance of non-small-cell lung cancer (NSCLC) cells.

Yin ZJ, Jin FG, Liu TG, Fu EQ, Xie YH, Sun RL.

J Surg Res. 2011 Dec;171(2):675-83. doi: 10.1016/j.jss.2010.03.053. Epub 2010 Apr 18.

PMID:
20605584
[PubMed - indexed for MEDLINE]
3.

Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.

Su L, Wang Y, Xiao M, Lin Y, Yu L.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 Oct;110(4):484-91. doi: 10.1016/j.tripleo.2010.04.009.

PMID:
20868995
[PubMed - indexed for MEDLINE]
4.

FoxM1 expression is significantly associated with cisplatin-based chemotherapy resistance and poor prognosis in advanced non-small cell lung cancer patients.

Wang Y, Wen L, Zhao SH, Ai ZH, Guo JZ, Liu WC.

Lung Cancer. 2013 Feb;79(2):173-9. doi: 10.1016/j.lungcan.2012.10.019. Epub 2012 Nov 20.

PMID:
23177020
[PubMed - indexed for MEDLINE]
5.

Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.

Zhao ZH, Wang SF, Yu L, Wang J, Chang H, Yan WL, Zhang J, Fu K.

Lung Cancer. 2008 Oct;62(1):113-9. doi: 10.1016/j.lungcan.2008.02.014. Epub 2008 Jun 11.

PMID:
18550205
[PubMed - indexed for MEDLINE]
6.

A multiple marker analysis of apoptosis-associated protein expression in non-small cell lung cancer in a Chinese population.

Fan CF, Xu HT, Lin XY, Yu JH, Wang EH.

Folia Histochem Cytobiol. 2011;49(2):231-9.

PMID:
21744322
[PubMed - indexed for MEDLINE]
Free Article
7.

Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.

Dong X, Lin D, Low C, Vucic EA, English JC, Yee J, Murray N, Lam WL, Ling V, Lam S, Gout PW, Wang Y.

J Thorac Oncol. 2013 Feb;8(2):161-70. doi: 10.1097/JTO.0b013e31827d5237.

PMID:
23287853
[PubMed - indexed for MEDLINE]
8.

[Correlation analysis among expression of ERCC-1, metallothionein, p53 and platinum resistance and prognosis in advanced non-small cell lung cancer].

Huang PY, Liang XM, Lin SX, Luo RZ, Hou JH, Zhang L.

Ai Zheng. 2004 Jul;23(7):845-50. Chinese.

PMID:
15248926
[PubMed - indexed for MEDLINE]
9.

Decreased tumstatin-mRNA is associated with poor outcome in patients with NSCLC.

Luo YQ, Ming Z, Zhao L, Yao LJ, Dong H, Du JP, Wu SZ, Hu W.

IUBMB Life. 2012 May;64(5):423-31. doi: 10.1002/iub.1016. Epub 2012 Mar 31.

PMID:
22473740
[PubMed - indexed for MEDLINE]
10.

JAK2/STAT3 signaling pathway activation mediates tumor angiogenesis by upregulation of VEGF and bFGF in non-small-cell lung cancer.

Zhao M, Gao FH, Wang JY, Liu F, Yuan HH, Zhang WY, Jiang B.

Lung Cancer. 2011 Sep;73(3):366-74. doi: 10.1016/j.lungcan.2011.01.002. Epub 2011 Feb 17.

PMID:
21333372
[PubMed - indexed for MEDLINE]
11.

Cyclooxygenase-2-dependent activation of signal transducer and activator of transcription 3 by interleukin-6 in non-small cell lung cancer.

Dalwadi H, Krysan K, Heuze-Vourc'h N, Dohadwala M, Elashoff D, Sharma S, Cacalano N, Lichtenstein A, Dubinett S.

Clin Cancer Res. 2005 Nov 1;11(21):7674-82.

PMID:
16278387
[PubMed - indexed for MEDLINE]
Free Article
12.

Total cyclooxygenase-2 mRNA levels correlate with vascular endothelial growth factor mRNA levels, tumor angiogenesis and prognosis in non-small cell lung cancer patients.

Yuan A, Yu CJ, Shun CT, Luh KT, Kuo SH, Lee YC, Yang PC.

Int J Cancer. 2005 Jul 1;115(4):545-55.

PMID:
15704107
[PubMed - indexed for MEDLINE]
13.

[Effects of JAK2/STAT3 signaling pathway on angiogenesis in non-small cell lung cancer].

Zhao M, Liu F, Wang JY, Zhang WY, Gao FH, Jiang B.

Zhonghua Yi Xue Za Zhi. 2011 Feb 15;91(6):375-81. Chinese.

PMID:
21418908
[PubMed - indexed for MEDLINE]
14.

Activated epidermal growth factor receptor-Stat-3 signaling promotes tumor survival in vivo in non-small cell lung cancer.

Haura EB, Zheng Z, Song L, Cantor A, Bepler G.

Clin Cancer Res. 2005 Dec 1;11(23):8288-94.

PMID:
16322287
[PubMed - indexed for MEDLINE]
Free Article
15.

Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival.

Liao WT, Wang X, Xu LH, Kong QL, Yu CP, Li MZ, Shi L, Zeng MS, Song LB.

Cancer. 2009 Apr 1;115(7):1507-17. doi: 10.1002/cncr.24128.

PMID:
19170237
[PubMed - indexed for MEDLINE]
Free Article
16.

APE1 overexpression is associated with cisplatin resistance in non-small cell lung cancer and targeted inhibition of APE1 enhances the activity of cisplatin in A549 cells.

Wang D, Xiang DB, Yang XQ, Chen LS, Li MX, Zhong ZY, Zhang YS.

Lung Cancer. 2009 Dec;66(3):298-304. doi: 10.1016/j.lungcan.2009.02.019. Epub 2009 Mar 25.

PMID:
19324449
[PubMed - indexed for MEDLINE]
17.

High expression of the transcriptional co-activator p300 predicts poor survival in resectable non-small cell lung cancers.

Hou X, Li Y, Luo RZ, Fu JH, He JH, Zhang LJ, Yang HX.

Eur J Surg Oncol. 2012 Jun;38(6):523-30. doi: 10.1016/j.ejso.2012.02.180. Epub 2012 Mar 21.

PMID:
22440742
[PubMed - indexed for MEDLINE]
18.

Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene.

Song X, Liu X, Chi W, Liu Y, Wei L, Wang X, Yu J.

Cancer Chemother Pharmacol. 2006 Dec;58(6):776-84. Epub 2006 Mar 11.

PMID:
16532342
[PubMed - indexed for MEDLINE]
19.

UbcH10 expression provides a useful tool for the prognosis and treatment of non-small cell lung cancer.

Zhao L, Jiang L, Wang L, He J, Yu H, Sun G, Chen J, Xiu Q, Li B.

J Cancer Res Clin Oncol. 2012 Nov;138(11):1951-61. doi: 10.1007/s00432-012-1275-2. Epub 2012 Jul 4.

PMID:
22760214
[PubMed - indexed for MEDLINE]
20.

MicroRNA-21 (miR-21) expression promotes growth, metastasis, and chemo- or radioresistance in non-small cell lung cancer cells by targeting PTEN.

Liu ZL, Wang H, Liu J, Wang ZX.

Mol Cell Biochem. 2013 Jan;372(1-2):35-45. doi: 10.1007/s11010-012-1443-3. Epub 2012 Sep 6.

PMID:
22956424
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk